A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Clinical Trial Grant
Awarded By
Ayala Pharmaceuticals, Inc
Start Date
November 12, 2021
End Date
March 26, 2024
Awarded By
Ayala Pharmaceuticals, Inc
Start Date
November 12, 2021
End Date
March 26, 2024